A case of dense deposit disease associated with a group A streptococcal infection without the involvement of C3NeF or complement factor H deficiency |
| |
Authors: | Kenichi Suga Shuji Kondo Sato Matsuura Yukiko Kinoshita Etsuko Kitano Michiyo Hatanaka Hajime Kitamura Yoshihiko Hidaka Takashi Oda Shoji Kagami |
| |
Affiliation: | (1) Department of Pediatrics, The Institute of Health Bioscience, The University of Tokushima Graduate School, Tokushima University, 18-15 Kuramotocho-3 chome, Tokushima city Tokushima, 770-8503, Japan;(2) Department of Medical Technology, Kobe Tokiwa University, Kobe, Japan;(3) Department of Nutritional Sciences for Well-being, Kansai University of Welfare Sciences, Kashiwara, Osaka, Japan;(4) Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Nagano, Japan;(5) Department of Nephrology, National Defense Medical College, Tokorozawa, Saitama, Japan |
| |
Abstract: | A 14-year-old girl presented with acute glomerulonephritis. Tests revealed hypocomplementemia and elevated Antistreptolysin-O titers, and renal biopsy revealed endocapillary and mesangial proliferative glomerulonephritis with double contours of the glomerular basement membrane (GBM). Despite methylprednisolone pulse therapy and the administration of oral prednisolone, overt proteinuria and hypocomplementemia persisted. A second renal biopsy 6 months later confirmed the initial diagnosis of dense deposit disease (DDD) based on electron-dense deposits in the GBM. C3 nephritic factor (C3NeF) and a deficiency of complement factor H (CFH) were not evident. A nephritis-associated plasmin receptor (NAPlr), nephritogenic group A streptococcal antigen, and the plasmin activity by in situ zymography were been in both the first and second biopsy specimens. The patient received combined immunomodulatory therapy with prednisolone and mizoribine, and the urinary protein decreased to a mild level at 27 months after disease onset. These findings suggest that persistent glomerular NAPlr deposition may be associated with the pathogenesis of DDD in some patients without the involvement of C3NeF or CFH mutation and that DDD patients of this type may respond to immunomodulatory treatment. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|